nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—CYP3A7—Sorafenib—liver cancer	0.0803	0.152	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0803	0.152	CbGbCtD
Ifosfamide—CYP2B6—Sorafenib—liver cancer	0.0764	0.145	CbGbCtD
Ifosfamide—CYP3A5—Sorafenib—liver cancer	0.0602	0.114	CbGbCtD
Ifosfamide—CYP2C8—Sorafenib—liver cancer	0.0579	0.11	CbGbCtD
Ifosfamide—CYP2C19—Sorafenib—liver cancer	0.0486	0.092	CbGbCtD
Ifosfamide—CYP2B6—Doxorubicin—liver cancer	0.0464	0.0878	CbGbCtD
Ifosfamide—CYP2C9—Sorafenib—liver cancer	0.0404	0.0765	CbGbCtD
Ifosfamide—CYP3A4—Sorafenib—liver cancer	0.0235	0.0445	CbGbCtD
Ifosfamide—CYP3A4—Doxorubicin—liver cancer	0.0142	0.027	CbGbCtD
Ifosfamide—Salivary hypersecretion—Epirubicin—liver cancer	0.000428	0.00128	CcSEcCtD
Ifosfamide—Anaphylactic shock—Sorafenib—liver cancer	0.000425	0.00127	CcSEcCtD
Ifosfamide—Colitis—Epirubicin—liver cancer	0.000423	0.00126	CcSEcCtD
Ifosfamide—Infection—Sorafenib—liver cancer	0.000422	0.00126	CcSEcCtD
Ifosfamide—Skin exfoliation—Epirubicin—liver cancer	0.000421	0.00126	CcSEcCtD
Ifosfamide—Inflammation—Doxorubicin—liver cancer	0.00042	0.00126	CcSEcCtD
Ifosfamide—Gait disturbance—Doxorubicin—liver cancer	0.000418	0.00125	CcSEcCtD
Ifosfamide—Nervous system disorder—Sorafenib—liver cancer	0.000417	0.00125	CcSEcCtD
Ifosfamide—Thrombocytopenia—Sorafenib—liver cancer	0.000416	0.00125	CcSEcCtD
Ifosfamide—Skin disorder—Sorafenib—liver cancer	0.000413	0.00124	CcSEcCtD
Ifosfamide—Ventricular tachycardia—Doxorubicin—liver cancer	0.000408	0.00122	CcSEcCtD
Ifosfamide—Pulmonary embolism—Doxorubicin—liver cancer	0.000408	0.00122	CcSEcCtD
Ifosfamide—Anorexia—Sorafenib—liver cancer	0.000405	0.00121	CcSEcCtD
Ifosfamide—Coma—Epirubicin—liver cancer	0.000403	0.0012	CcSEcCtD
Ifosfamide—Neoplasm—Epirubicin—liver cancer	0.000398	0.00119	CcSEcCtD
Ifosfamide—Salivary hypersecretion—Doxorubicin—liver cancer	0.000396	0.00118	CcSEcCtD
Ifosfamide—Pulmonary oedema—Epirubicin—liver cancer	0.000392	0.00117	CcSEcCtD
Ifosfamide—Colitis—Doxorubicin—liver cancer	0.000391	0.00117	CcSEcCtD
Ifosfamide—Skin exfoliation—Doxorubicin—liver cancer	0.000389	0.00116	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000387	0.00116	CcSEcCtD
Ifosfamide—Sepsis—Epirubicin—liver cancer	0.000382	0.00114	CcSEcCtD
Ifosfamide—Dyspnoea—Sorafenib—liver cancer	0.000379	0.00113	CcSEcCtD
Ifosfamide—Coma—Doxorubicin—liver cancer	0.000372	0.00111	CcSEcCtD
Ifosfamide—Phlebitis—Epirubicin—liver cancer	0.000371	0.00111	CcSEcCtD
Ifosfamide—Decreased appetite—Sorafenib—liver cancer	0.00037	0.00111	CcSEcCtD
Ifosfamide—Thrombophlebitis—Epirubicin—liver cancer	0.000369	0.0011	CcSEcCtD
Ifosfamide—Neoplasm—Doxorubicin—liver cancer	0.000369	0.0011	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Sorafenib—liver cancer	0.000367	0.0011	CcSEcCtD
Ifosfamide—Fatigue—Sorafenib—liver cancer	0.000367	0.0011	CcSEcCtD
Ifosfamide—Hepatic function abnormal—Epirubicin—liver cancer	0.000366	0.00109	CcSEcCtD
Ifosfamide—Pain—Sorafenib—liver cancer	0.000364	0.00109	CcSEcCtD
Ifosfamide—Constipation—Sorafenib—liver cancer	0.000364	0.00109	CcSEcCtD
Ifosfamide—Pulmonary oedema—Doxorubicin—liver cancer	0.000363	0.00108	CcSEcCtD
Ifosfamide—Hepatic failure—Epirubicin—liver cancer	0.000356	0.00106	CcSEcCtD
Ifosfamide—Sepsis—Doxorubicin—liver cancer	0.000354	0.00106	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Sorafenib—liver cancer	0.000348	0.00104	CcSEcCtD
Ifosfamide—Renal failure acute—Epirubicin—liver cancer	0.000346	0.00104	CcSEcCtD
Ifosfamide—Phlebitis—Doxorubicin—liver cancer	0.000343	0.00103	CcSEcCtD
Ifosfamide—Thrombophlebitis—Doxorubicin—liver cancer	0.000342	0.00102	CcSEcCtD
Ifosfamide—Hepatic function abnormal—Doxorubicin—liver cancer	0.000339	0.00101	CcSEcCtD
Ifosfamide—Urticaria—Sorafenib—liver cancer	0.000338	0.00101	CcSEcCtD
Ifosfamide—Body temperature increased—Sorafenib—liver cancer	0.000336	0.00101	CcSEcCtD
Ifosfamide—Abdominal pain—Sorafenib—liver cancer	0.000336	0.00101	CcSEcCtD
Ifosfamide—Renal impairment—Epirubicin—liver cancer	0.000336	0.001	CcSEcCtD
Ifosfamide—Hepatic failure—Doxorubicin—liver cancer	0.000329	0.000984	CcSEcCtD
Ifosfamide—Cardiac failure—Epirubicin—liver cancer	0.000328	0.00098	CcSEcCtD
Ifosfamide—Renal failure acute—Doxorubicin—liver cancer	0.00032	0.000958	CcSEcCtD
Ifosfamide—Pain in extremity—Epirubicin—liver cancer	0.00032	0.000956	CcSEcCtD
Ifosfamide—Osteoarthritis—Epirubicin—liver cancer	0.00032	0.000956	CcSEcCtD
Ifosfamide—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00032	0.000956	CcSEcCtD
Ifosfamide—Hypersensitivity—Sorafenib—liver cancer	0.000313	0.000937	CcSEcCtD
Ifosfamide—Renal impairment—Doxorubicin—liver cancer	0.000311	0.00093	CcSEcCtD
Ifosfamide—Asthenia—Sorafenib—liver cancer	0.000305	0.000912	CcSEcCtD
Ifosfamide—Cardiac arrest—Epirubicin—liver cancer	0.000304	0.000909	CcSEcCtD
Ifosfamide—Cardiac failure—Doxorubicin—liver cancer	0.000303	0.000907	CcSEcCtD
Ifosfamide—Pruritus—Sorafenib—liver cancer	0.000301	0.0009	CcSEcCtD
Ifosfamide—Blood creatinine increased—Epirubicin—liver cancer	0.0003	0.000896	CcSEcCtD
Ifosfamide—Osteoarthritis—Doxorubicin—liver cancer	0.000296	0.000885	CcSEcCtD
Ifosfamide—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000296	0.000885	CcSEcCtD
Ifosfamide—Pain in extremity—Doxorubicin—liver cancer	0.000296	0.000885	CcSEcCtD
Ifosfamide—Hypokalaemia—Epirubicin—liver cancer	0.000291	0.00087	CcSEcCtD
Ifosfamide—Diarrhoea—Sorafenib—liver cancer	0.000291	0.00087	CcSEcCtD
Ifosfamide—Breast disorder—Epirubicin—liver cancer	0.000289	0.000864	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000288	0.000861	CcSEcCtD
Ifosfamide—Cardiac arrest—Doxorubicin—liver cancer	0.000281	0.000841	CcSEcCtD
Ifosfamide—Dizziness—Sorafenib—liver cancer	0.000281	0.000841	CcSEcCtD
Ifosfamide—Blood creatinine increased—Doxorubicin—liver cancer	0.000277	0.000829	CcSEcCtD
Ifosfamide—Pancreatitis—Epirubicin—liver cancer	0.000271	0.00081	CcSEcCtD
Ifosfamide—Vomiting—Sorafenib—liver cancer	0.00027	0.000809	CcSEcCtD
Ifosfamide—Hypokalaemia—Doxorubicin—liver cancer	0.000269	0.000805	CcSEcCtD
Ifosfamide—Angina pectoris—Epirubicin—liver cancer	0.000269	0.000805	CcSEcCtD
Ifosfamide—Rash—Sorafenib—liver cancer	0.000268	0.000802	CcSEcCtD
Ifosfamide—Dermatitis—Sorafenib—liver cancer	0.000268	0.000801	CcSEcCtD
Ifosfamide—Breast disorder—Doxorubicin—liver cancer	0.000267	0.000799	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000266	0.000797	CcSEcCtD
Ifosfamide—Pancytopenia—Epirubicin—liver cancer	0.000262	0.000785	CcSEcCtD
Ifosfamide—Dysuria—Epirubicin—liver cancer	0.000258	0.000773	CcSEcCtD
Ifosfamide—Pollakiuria—Epirubicin—liver cancer	0.000255	0.000763	CcSEcCtD
Ifosfamide—Nausea—Sorafenib—liver cancer	0.000253	0.000755	CcSEcCtD
Ifosfamide—Pancreatitis—Doxorubicin—liver cancer	0.000251	0.00075	CcSEcCtD
Ifosfamide—Hyperglycaemia—Epirubicin—liver cancer	0.000249	0.000745	CcSEcCtD
Ifosfamide—Angina pectoris—Doxorubicin—liver cancer	0.000249	0.000745	CcSEcCtD
Ifosfamide—Pneumonia—Epirubicin—liver cancer	0.000248	0.000741	CcSEcCtD
Ifosfamide—Infestation—Epirubicin—liver cancer	0.000246	0.000737	CcSEcCtD
Ifosfamide—Infestation NOS—Epirubicin—liver cancer	0.000246	0.000737	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000244	0.000731	CcSEcCtD
Ifosfamide—Pancytopenia—Doxorubicin—liver cancer	0.000243	0.000726	CcSEcCtD
Ifosfamide—Renal failure—Epirubicin—liver cancer	0.000242	0.000724	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Epirubicin—liver cancer	0.000242	0.000722	CcSEcCtD
Ifosfamide—Stomatitis—Epirubicin—liver cancer	0.00024	0.000718	CcSEcCtD
Ifosfamide—Conjunctivitis—Epirubicin—liver cancer	0.00024	0.000716	CcSEcCtD
Ifosfamide—Dysuria—Doxorubicin—liver cancer	0.000239	0.000715	CcSEcCtD
Ifosfamide—Pollakiuria—Doxorubicin—liver cancer	0.000236	0.000706	CcSEcCtD
Ifosfamide—Haematuria—Epirubicin—liver cancer	0.000235	0.000703	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Epirubicin—liver cancer	0.000233	0.000697	CcSEcCtD
Ifosfamide—Hyperglycaemia—Doxorubicin—liver cancer	0.000231	0.00069	CcSEcCtD
Ifosfamide—Agranulocytosis—Epirubicin—liver cancer	0.00023	0.000688	CcSEcCtD
Ifosfamide—Pneumonia—Doxorubicin—liver cancer	0.000229	0.000686	CcSEcCtD
Ifosfamide—Infestation—Doxorubicin—liver cancer	0.000228	0.000682	CcSEcCtD
Ifosfamide—Infestation NOS—Doxorubicin—liver cancer	0.000228	0.000682	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000226	0.000676	CcSEcCtD
Ifosfamide—Bradycardia—Epirubicin—liver cancer	0.000225	0.000673	CcSEcCtD
Ifosfamide—Renal failure—Doxorubicin—liver cancer	0.000224	0.00067	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Doxorubicin—liver cancer	0.000223	0.000668	CcSEcCtD
Ifosfamide—Haemoglobin—Epirubicin—liver cancer	0.000222	0.000665	CcSEcCtD
Ifosfamide—Stomatitis—Doxorubicin—liver cancer	0.000222	0.000665	CcSEcCtD
Ifosfamide—Conjunctivitis—Doxorubicin—liver cancer	0.000222	0.000663	CcSEcCtD
Ifosfamide—Haemorrhage—Epirubicin—liver cancer	0.000221	0.000661	CcSEcCtD
Ifosfamide—Hepatitis—Epirubicin—liver cancer	0.000221	0.000661	CcSEcCtD
Ifosfamide—Urinary tract disorder—Epirubicin—liver cancer	0.000218	0.000653	CcSEcCtD
Ifosfamide—Haematuria—Doxorubicin—liver cancer	0.000217	0.00065	CcSEcCtD
Ifosfamide—Connective tissue disorder—Epirubicin—liver cancer	0.000217	0.00065	CcSEcCtD
Ifosfamide—Urethral disorder—Epirubicin—liver cancer	0.000217	0.000648	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Doxorubicin—liver cancer	0.000216	0.000645	CcSEcCtD
Ifosfamide—Visual impairment—Epirubicin—liver cancer	0.000213	0.000637	CcSEcCtD
Ifosfamide—Agranulocytosis—Doxorubicin—liver cancer	0.000213	0.000636	CcSEcCtD
Ifosfamide—Erythema multiforme—Epirubicin—liver cancer	0.000209	0.000625	CcSEcCtD
Ifosfamide—Bradycardia—Doxorubicin—liver cancer	0.000208	0.000623	CcSEcCtD
Ifosfamide—Eye disorder—Epirubicin—liver cancer	0.000207	0.000618	CcSEcCtD
Ifosfamide—Tinnitus—Epirubicin—liver cancer	0.000206	0.000617	CcSEcCtD
Ifosfamide—Haemoglobin—Doxorubicin—liver cancer	0.000206	0.000615	CcSEcCtD
Ifosfamide—Cardiac disorder—Epirubicin—liver cancer	0.000205	0.000614	CcSEcCtD
Ifosfamide—Flushing—Epirubicin—liver cancer	0.000205	0.000614	CcSEcCtD
Ifosfamide—Haemorrhage—Doxorubicin—liver cancer	0.000205	0.000612	CcSEcCtD
Ifosfamide—Hepatitis—Doxorubicin—liver cancer	0.000205	0.000612	CcSEcCtD
Ifosfamide—Urinary tract disorder—Doxorubicin—liver cancer	0.000202	0.000604	CcSEcCtD
Ifosfamide—Connective tissue disorder—Doxorubicin—liver cancer	0.000201	0.000601	CcSEcCtD
Ifosfamide—Angiopathy—Epirubicin—liver cancer	0.000201	0.0006	CcSEcCtD
Ifosfamide—Urethral disorder—Doxorubicin—liver cancer	0.000201	0.0006	CcSEcCtD
Ifosfamide—Immune system disorder—Epirubicin—liver cancer	0.0002	0.000597	CcSEcCtD
Ifosfamide—Mediastinal disorder—Epirubicin—liver cancer	0.000199	0.000596	CcSEcCtD
Ifosfamide—Chills—Epirubicin—liver cancer	0.000198	0.000594	CcSEcCtD
Ifosfamide—Arrhythmia—Epirubicin—liver cancer	0.000198	0.000591	CcSEcCtD
Ifosfamide—Visual impairment—Doxorubicin—liver cancer	0.000197	0.00059	CcSEcCtD
Ifosfamide—Alopecia—Epirubicin—liver cancer	0.000195	0.000585	CcSEcCtD
Ifosfamide—Mental disorder—Epirubicin—liver cancer	0.000194	0.00058	CcSEcCtD
Ifosfamide—Erythema multiforme—Doxorubicin—liver cancer	0.000194	0.000579	CcSEcCtD
Ifosfamide—Erythema—Epirubicin—liver cancer	0.000193	0.000576	CcSEcCtD
Ifosfamide—Malnutrition—Epirubicin—liver cancer	0.000193	0.000576	CcSEcCtD
Ifosfamide—Eye disorder—Doxorubicin—liver cancer	0.000191	0.000572	CcSEcCtD
Ifosfamide—Tinnitus—Doxorubicin—liver cancer	0.000191	0.000571	CcSEcCtD
Ifosfamide—Flushing—Doxorubicin—liver cancer	0.00019	0.000568	CcSEcCtD
Ifosfamide—Cardiac disorder—Doxorubicin—liver cancer	0.00019	0.000568	CcSEcCtD
Ifosfamide—Angiopathy—Doxorubicin—liver cancer	0.000186	0.000555	CcSEcCtD
Ifosfamide—Immune system disorder—Doxorubicin—liver cancer	0.000185	0.000553	CcSEcCtD
Ifosfamide—Mediastinal disorder—Doxorubicin—liver cancer	0.000184	0.000552	CcSEcCtD
Ifosfamide—Chills—Doxorubicin—liver cancer	0.000184	0.000549	CcSEcCtD
Ifosfamide—Arrhythmia—Doxorubicin—liver cancer	0.000183	0.000547	CcSEcCtD
Ifosfamide—Vision blurred—Epirubicin—liver cancer	0.000181	0.000543	CcSEcCtD
Ifosfamide—Alopecia—Doxorubicin—liver cancer	0.000181	0.000541	CcSEcCtD
Ifosfamide—Mental disorder—Doxorubicin—liver cancer	0.000179	0.000536	CcSEcCtD
Ifosfamide—Ill-defined disorder—Epirubicin—liver cancer	0.000179	0.000534	CcSEcCtD
Ifosfamide—Erythema—Doxorubicin—liver cancer	0.000178	0.000533	CcSEcCtD
Ifosfamide—Malnutrition—Doxorubicin—liver cancer	0.000178	0.000533	CcSEcCtD
Ifosfamide—Anaemia—Epirubicin—liver cancer	0.000178	0.000532	CcSEcCtD
Ifosfamide—Agitation—Epirubicin—liver cancer	0.000177	0.000529	CcSEcCtD
Ifosfamide—Malaise—Epirubicin—liver cancer	0.000174	0.000519	CcSEcCtD
Ifosfamide—Vertigo—Epirubicin—liver cancer	0.000173	0.000517	CcSEcCtD
Ifosfamide—Leukopenia—Epirubicin—liver cancer	0.000172	0.000515	CcSEcCtD
Ifosfamide—Palpitations—Epirubicin—liver cancer	0.00017	0.000509	CcSEcCtD
Ifosfamide—Cough—Epirubicin—liver cancer	0.000168	0.000502	CcSEcCtD
Ifosfamide—Vision blurred—Doxorubicin—liver cancer	0.000168	0.000502	CcSEcCtD
Ifosfamide—Convulsion—Epirubicin—liver cancer	0.000167	0.000499	CcSEcCtD
Ifosfamide—Hypertension—Epirubicin—liver cancer	0.000166	0.000497	CcSEcCtD
Ifosfamide—Ill-defined disorder—Doxorubicin—liver cancer	0.000165	0.000494	CcSEcCtD
Ifosfamide—Anaemia—Doxorubicin—liver cancer	0.000165	0.000492	CcSEcCtD
Ifosfamide—Chest pain—Epirubicin—liver cancer	0.000164	0.00049	CcSEcCtD
Ifosfamide—Myalgia—Epirubicin—liver cancer	0.000164	0.00049	CcSEcCtD
Ifosfamide—Arthralgia—Epirubicin—liver cancer	0.000164	0.00049	CcSEcCtD
Ifosfamide—Agitation—Doxorubicin—liver cancer	0.000164	0.00049	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000163	0.000487	CcSEcCtD
Ifosfamide—Discomfort—Epirubicin—liver cancer	0.000162	0.000484	CcSEcCtD
Ifosfamide—Malaise—Doxorubicin—liver cancer	0.000161	0.00048	CcSEcCtD
Ifosfamide—Vertigo—Doxorubicin—liver cancer	0.00016	0.000479	CcSEcCtD
Ifosfamide—Leukopenia—Doxorubicin—liver cancer	0.000159	0.000477	CcSEcCtD
Ifosfamide—Confusional state—Epirubicin—liver cancer	0.000158	0.000474	CcSEcCtD
Ifosfamide—Palpitations—Doxorubicin—liver cancer	0.000157	0.000471	CcSEcCtD
Ifosfamide—Oedema—Epirubicin—liver cancer	0.000157	0.00047	CcSEcCtD
Ifosfamide—Anaphylactic shock—Epirubicin—liver cancer	0.000157	0.00047	CcSEcCtD
Ifosfamide—Infection—Epirubicin—liver cancer	0.000156	0.000467	CcSEcCtD
Ifosfamide—Cough—Doxorubicin—liver cancer	0.000155	0.000465	CcSEcCtD
Ifosfamide—Convulsion—Doxorubicin—liver cancer	0.000154	0.000462	CcSEcCtD
Ifosfamide—Nervous system disorder—Epirubicin—liver cancer	0.000154	0.000461	CcSEcCtD
Ifosfamide—Thrombocytopenia—Epirubicin—liver cancer	0.000154	0.00046	CcSEcCtD
Ifosfamide—Hypertension—Doxorubicin—liver cancer	0.000154	0.00046	CcSEcCtD
Ifosfamide—Skin disorder—Epirubicin—liver cancer	0.000153	0.000456	CcSEcCtD
Ifosfamide—Hyperhidrosis—Epirubicin—liver cancer	0.000152	0.000454	CcSEcCtD
Ifosfamide—Myalgia—Doxorubicin—liver cancer	0.000152	0.000454	CcSEcCtD
Ifosfamide—Chest pain—Doxorubicin—liver cancer	0.000152	0.000454	CcSEcCtD
Ifosfamide—Arthralgia—Doxorubicin—liver cancer	0.000152	0.000454	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000151	0.00045	CcSEcCtD
Ifosfamide—Discomfort—Doxorubicin—liver cancer	0.00015	0.000448	CcSEcCtD
Ifosfamide—Anorexia—Epirubicin—liver cancer	0.00015	0.000448	CcSEcCtD
Ifosfamide—Hypotension—Epirubicin—liver cancer	0.000147	0.000439	CcSEcCtD
Ifosfamide—Confusional state—Doxorubicin—liver cancer	0.000147	0.000438	CcSEcCtD
Ifosfamide—Oedema—Doxorubicin—liver cancer	0.000145	0.000435	CcSEcCtD
Ifosfamide—Anaphylactic shock—Doxorubicin—liver cancer	0.000145	0.000435	CcSEcCtD
Ifosfamide—Infection—Doxorubicin—liver cancer	0.000144	0.000432	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000143	0.000428	CcSEcCtD
Ifosfamide—Nervous system disorder—Doxorubicin—liver cancer	0.000143	0.000426	CcSEcCtD
Ifosfamide—Thrombocytopenia—Doxorubicin—liver cancer	0.000142	0.000426	CcSEcCtD
Ifosfamide—Skin disorder—Doxorubicin—liver cancer	0.000141	0.000422	CcSEcCtD
Ifosfamide—Paraesthesia—Epirubicin—liver cancer	0.000141	0.000422	CcSEcCtD
Ifosfamide—Hyperhidrosis—Doxorubicin—liver cancer	0.000141	0.00042	CcSEcCtD
Ifosfamide—Dyspnoea—Epirubicin—liver cancer	0.00014	0.000419	CcSEcCtD
Ifosfamide—Somnolence—Epirubicin—liver cancer	0.00014	0.000418	CcSEcCtD
Ifosfamide—Anorexia—Doxorubicin—liver cancer	0.000139	0.000414	CcSEcCtD
Ifosfamide—Decreased appetite—Epirubicin—liver cancer	0.000137	0.000409	CcSEcCtD
Ifosfamide—Hypotension—Doxorubicin—liver cancer	0.000136	0.000406	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Epirubicin—liver cancer	0.000136	0.000406	CcSEcCtD
Ifosfamide—Fatigue—Epirubicin—liver cancer	0.000135	0.000405	CcSEcCtD
Ifosfamide—Pain—Epirubicin—liver cancer	0.000134	0.000402	CcSEcCtD
Ifosfamide—Constipation—Epirubicin—liver cancer	0.000134	0.000402	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000132	0.000396	CcSEcCtD
Ifosfamide—Paraesthesia—Doxorubicin—liver cancer	0.000131	0.00039	CcSEcCtD
Ifosfamide—Dyspnoea—Doxorubicin—liver cancer	0.00013	0.000388	CcSEcCtD
Ifosfamide—Feeling abnormal—Epirubicin—liver cancer	0.00013	0.000387	CcSEcCtD
Ifosfamide—Somnolence—Doxorubicin—liver cancer	0.000129	0.000387	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Epirubicin—liver cancer	0.000129	0.000384	CcSEcCtD
Ifosfamide—Decreased appetite—Doxorubicin—liver cancer	0.000126	0.000378	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000126	0.000375	CcSEcCtD
Ifosfamide—Fatigue—Doxorubicin—liver cancer	0.000125	0.000375	CcSEcCtD
Ifosfamide—Urticaria—Epirubicin—liver cancer	0.000125	0.000373	CcSEcCtD
Ifosfamide—Constipation—Doxorubicin—liver cancer	0.000124	0.000372	CcSEcCtD
Ifosfamide—Pain—Doxorubicin—liver cancer	0.000124	0.000372	CcSEcCtD
Ifosfamide—Abdominal pain—Epirubicin—liver cancer	0.000124	0.000372	CcSEcCtD
Ifosfamide—Body temperature increased—Epirubicin—liver cancer	0.000124	0.000372	CcSEcCtD
Ifosfamide—Feeling abnormal—Doxorubicin—liver cancer	0.00012	0.000358	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Doxorubicin—liver cancer	0.000119	0.000356	CcSEcCtD
Ifosfamide—Hypersensitivity—Epirubicin—liver cancer	0.000116	0.000346	CcSEcCtD
Ifosfamide—Urticaria—Doxorubicin—liver cancer	0.000116	0.000345	CcSEcCtD
Ifosfamide—Abdominal pain—Doxorubicin—liver cancer	0.000115	0.000344	CcSEcCtD
Ifosfamide—Body temperature increased—Doxorubicin—liver cancer	0.000115	0.000344	CcSEcCtD
Ifosfamide—Asthenia—Epirubicin—liver cancer	0.000113	0.000337	CcSEcCtD
Ifosfamide—Pruritus—Epirubicin—liver cancer	0.000111	0.000332	CcSEcCtD
Ifosfamide—Diarrhoea—Epirubicin—liver cancer	0.000108	0.000322	CcSEcCtD
Ifosfamide—Hypersensitivity—Doxorubicin—liver cancer	0.000107	0.00032	CcSEcCtD
Ifosfamide—Asthenia—Doxorubicin—liver cancer	0.000104	0.000312	CcSEcCtD
Ifosfamide—Dizziness—Epirubicin—liver cancer	0.000104	0.000311	CcSEcCtD
Ifosfamide—Pruritus—Doxorubicin—liver cancer	0.000103	0.000308	CcSEcCtD
Ifosfamide—Vomiting—Epirubicin—liver cancer	9.99e-05	0.000299	CcSEcCtD
Ifosfamide—Diarrhoea—Doxorubicin—liver cancer	9.95e-05	0.000298	CcSEcCtD
Ifosfamide—Rash—Epirubicin—liver cancer	9.91e-05	0.000296	CcSEcCtD
Ifosfamide—Dermatitis—Epirubicin—liver cancer	9.9e-05	0.000296	CcSEcCtD
Ifosfamide—Dizziness—Doxorubicin—liver cancer	9.62e-05	0.000288	CcSEcCtD
Ifosfamide—Nausea—Epirubicin—liver cancer	9.33e-05	0.000279	CcSEcCtD
Ifosfamide—Vomiting—Doxorubicin—liver cancer	9.25e-05	0.000276	CcSEcCtD
Ifosfamide—Rash—Doxorubicin—liver cancer	9.17e-05	0.000274	CcSEcCtD
Ifosfamide—Dermatitis—Doxorubicin—liver cancer	9.16e-05	0.000274	CcSEcCtD
Ifosfamide—Nausea—Doxorubicin—liver cancer	8.64e-05	0.000258	CcSEcCtD
Ifosfamide—CYP3A5—Metabolism—CRABP1—liver cancer	2.67e-05	0.000194	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.66e-05	0.000193	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTA3—liver cancer	2.65e-05	0.000193	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—MTHFR—liver cancer	2.65e-05	0.000193	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTA2—liver cancer	2.65e-05	0.000193	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PSMA4—liver cancer	2.64e-05	0.000192	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PSMD10—liver cancer	2.64e-05	0.000192	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CYP2E1—liver cancer	2.63e-05	0.000192	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—EPT1—liver cancer	2.61e-05	0.00019	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PPARA—liver cancer	2.6e-05	0.000189	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GOT2—liver cancer	2.57e-05	0.000187	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTA1—liver cancer	2.56e-05	0.000186	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CPT1B—liver cancer	2.55e-05	0.000186	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GLUL—liver cancer	2.55e-05	0.000186	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CYP2E1—liver cancer	2.55e-05	0.000186	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—NAT2—liver cancer	2.53e-05	0.000184	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—TAT—liver cancer	2.48e-05	0.00018	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.47e-05	0.00018	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CYCS—liver cancer	2.46e-05	0.000179	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NR1H4—liver cancer	2.46e-05	0.000179	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.43e-05	0.000177	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTA4—liver cancer	2.43e-05	0.000177	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ALDOB—liver cancer	2.42e-05	0.000176	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTA3—liver cancer	2.42e-05	0.000176	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GOT1—liver cancer	2.42e-05	0.000176	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GGT1—liver cancer	2.42e-05	0.000176	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYP2E1—liver cancer	2.41e-05	0.000176	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—HPGDS—liver cancer	2.39e-05	0.000174	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CYCS—liver cancer	2.39e-05	0.000174	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.37e-05	0.000173	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTA2—liver cancer	2.37e-05	0.000172	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GGT1—liver cancer	2.34e-05	0.00017	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GOT1—liver cancer	2.34e-05	0.00017	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—HPGDS—liver cancer	2.33e-05	0.00017	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CRABP1—liver cancer	2.31e-05	0.000168	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTA1—liver cancer	2.28e-05	0.000166	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYCS—liver cancer	2.26e-05	0.000164	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NAT2—liver cancer	2.26e-05	0.000164	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CG—liver cancer	2.23e-05	0.000162	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GOT1—liver cancer	2.22e-05	0.000161	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GGT1—liver cancer	2.22e-05	0.000161	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTA4—liver cancer	2.21e-05	0.000161	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GSTP1—liver cancer	2.17e-05	0.000158	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.17e-05	0.000158	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ALDOB—liver cancer	2.16e-05	0.000157	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.16e-05	0.000157	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTA2—liver cancer	2.16e-05	0.000157	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PPARG—liver cancer	2.15e-05	0.000156	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—HMOX1—liver cancer	2.14e-05	0.000156	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PSMA4—liver cancer	2.13e-05	0.000155	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PSMD10—liver cancer	2.13e-05	0.000155	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GSTP1—liver cancer	2.1e-05	0.000153	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.08e-05	0.000152	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTA1—liver cancer	2.08e-05	0.000151	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PSMA4—liver cancer	2.08e-05	0.000151	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PSMD10—liver cancer	2.08e-05	0.000151	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—HMOX1—liver cancer	2.08e-05	0.000151	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GOT2—liver cancer	2.07e-05	0.000151	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CRABP1—liver cancer	2.06e-05	0.00015	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NAT2—liver cancer	2.06e-05	0.00015	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GOT2—liver cancer	2.02e-05	0.000147	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—HPGDS—liver cancer	2.02e-05	0.000147	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.01e-05	0.000146	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GSTM1—liver cancer	1.99e-05	0.000145	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GSTP1—liver cancer	1.99e-05	0.000145	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.98e-05	0.000144	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALDOB—liver cancer	1.97e-05	0.000144	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—HMOX1—liver cancer	1.96e-05	0.000143	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CD—liver cancer	1.96e-05	0.000143	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP2E1—liver cancer	1.95e-05	0.000142	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GSTM1—liver cancer	1.93e-05	0.000141	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—ALB—liver cancer	1.93e-05	0.000141	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP2E1—liver cancer	1.9e-05	0.000138	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CYP1A1—liver cancer	1.89e-05	0.000138	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CRABP1—liver cancer	1.88e-05	0.000137	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.86e-05	0.000135	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CYP1A1—liver cancer	1.83e-05	0.000133	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.83e-05	0.000133	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GSTM1—liver cancer	1.83e-05	0.000133	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYCS—liver cancer	1.82e-05	0.000133	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.81e-05	0.000132	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—HPGDS—liver cancer	1.8e-05	0.000131	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PSMA4—liver cancer	1.8e-05	0.000131	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PSMD10—liver cancer	1.8e-05	0.000131	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.79e-05	0.000131	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GOT1—liver cancer	1.79e-05	0.00013	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GGT1—liver cancer	1.79e-05	0.00013	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYCS—liver cancer	1.78e-05	0.00013	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—MTHFR—liver cancer	1.76e-05	0.000128	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GOT2—liver cancer	1.75e-05	0.000128	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GGT1—liver cancer	1.75e-05	0.000127	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GOT1—liver cancer	1.75e-05	0.000127	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYP1A1—liver cancer	1.73e-05	0.000126	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PPARA—liver cancer	1.73e-05	0.000126	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—MTHFR—liver cancer	1.71e-05	0.000124	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CB—liver cancer	1.71e-05	0.000124	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.69e-05	0.000123	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CPT1B—liver cancer	1.68e-05	0.000123	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GLUL—liver cancer	1.68e-05	0.000123	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PPARA—liver cancer	1.68e-05	0.000122	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP2E1—liver cancer	1.65e-05	0.00012	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—HPGDS—liver cancer	1.65e-05	0.00012	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.64e-05	0.000119	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.63e-05	0.000119	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NR1H4—liver cancer	1.62e-05	0.000118	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—MTHFR—liver cancer	1.62e-05	0.000118	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.61e-05	0.000117	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PSMA4—liver cancer	1.61e-05	0.000117	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PSMD10—liver cancer	1.61e-05	0.000117	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTP1—liver cancer	1.61e-05	0.000117	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTA3—liver cancer	1.6e-05	0.000116	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.6e-05	0.000116	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PPARA—liver cancer	1.59e-05	0.000115	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—HMOX1—liver cancer	1.58e-05	0.000115	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTP1—liver cancer	1.57e-05	0.000114	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GOT2—liver cancer	1.56e-05	0.000114	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—HMOX1—liver cancer	1.55e-05	0.000113	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYCS—liver cancer	1.54e-05	0.000112	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GGT1—liver cancer	1.51e-05	0.00011	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GOT1—liver cancer	1.51e-05	0.00011	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.51e-05	0.00011	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.49e-05	0.000108	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CG—liver cancer	1.48e-05	0.000108	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTM1—liver cancer	1.48e-05	0.000107	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP2E1—liver cancer	1.47e-05	0.000107	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.47e-05	0.000107	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PSMA4—liver cancer	1.47e-05	0.000107	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PSMD10—liver cancer	1.47e-05	0.000107	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTA4—liver cancer	1.46e-05	0.000106	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTM1—liver cancer	1.44e-05	0.000105	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CG—liver cancer	1.44e-05	0.000104	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PPARG—liver cancer	1.43e-05	0.000104	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GOT2—liver cancer	1.43e-05	0.000104	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.42e-05	0.000104	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTA2—liver cancer	1.42e-05	0.000104	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP1A1—liver cancer	1.4e-05	0.000102	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PPARG—liver cancer	1.39e-05	0.000101	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYCS—liver cancer	1.38e-05	0.0001	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTA1—liver cancer	1.37e-05	9.99e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP1A1—liver cancer	1.37e-05	9.95e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTP1—liver cancer	1.36e-05	9.89e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CG—liver cancer	1.36e-05	9.88e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NAT2—liver cancer	1.36e-05	9.88e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GOT1—liver cancer	1.35e-05	9.83e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GGT1—liver cancer	1.35e-05	9.83e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP2E1—liver cancer	1.34e-05	9.76e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—HMOX1—liver cancer	1.34e-05	9.75e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PPARG—liver cancer	1.31e-05	9.54e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—MTHFR—liver cancer	1.3e-05	9.49e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CD—liver cancer	1.3e-05	9.48e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALDOB—liver cancer	1.3e-05	9.47e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.3e-05	9.45e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ALB—liver cancer	1.29e-05	9.35e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PPARA—liver cancer	1.28e-05	9.31e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—MTHFR—liver cancer	1.27e-05	9.27e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CD—liver cancer	1.26e-05	9.18e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYCS—liver cancer	1.25e-05	9.13e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PPARA—liver cancer	1.25e-05	9.1e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTM1—liver cancer	1.25e-05	9.09e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ALB—liver cancer	1.25e-05	9.07e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CRABP1—liver cancer	1.24e-05	9.03e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GGT1—liver cancer	1.23e-05	8.96e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GOT1—liver cancer	1.23e-05	8.96e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTP1—liver cancer	1.21e-05	8.83e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—HMOX1—liver cancer	1.2e-05	8.71e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CD—liver cancer	1.19e-05	8.69e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP1A1—liver cancer	1.18e-05	8.62e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ALB—liver cancer	1.18e-05	8.57e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CB—liver cancer	1.14e-05	8.26e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTM1—liver cancer	1.11e-05	8.11e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTP1—liver cancer	1.11e-05	8.05e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—MTHFR—liver cancer	1.1e-05	8.03e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CB—liver cancer	1.1e-05	8.01e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CG—liver cancer	1.1e-05	7.97e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—HMOX1—liver cancer	1.09e-05	7.94e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HPGDS—liver cancer	1.09e-05	7.9e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PPARA—liver cancer	1.08e-05	7.88e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CG—liver cancer	1.07e-05	7.79e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PPARG—liver cancer	1.06e-05	7.69e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP1A1—liver cancer	1.06e-05	7.69e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CA—liver cancer	1.04e-05	7.57e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CB—liver cancer	1.04e-05	7.57e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PPARG—liver cancer	1.03e-05	7.52e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTM1—liver cancer	1.02e-05	7.4e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—MTHFR—liver cancer	9.85e-06	7.17e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.73e-06	7.08e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PSMA4—liver cancer	9.67e-06	7.04e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PSMD10—liver cancer	9.67e-06	7.04e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PPARA—liver cancer	9.67e-06	7.03e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP1A1—liver cancer	9.64e-06	7.01e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CD—liver cancer	9.63e-06	7.01e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ALB—liver cancer	9.51e-06	6.92e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CD—liver cancer	9.41e-06	6.85e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GOT2—liver cancer	9.41e-06	6.85e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ALB—liver cancer	9.29e-06	6.76e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CG—liver cancer	9.27e-06	6.75e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—MTHFR—liver cancer	8.98e-06	6.54e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PPARG—liver cancer	8.95e-06	6.51e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP2E1—liver cancer	8.85e-06	6.44e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PPARA—liver cancer	8.81e-06	6.41e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.68e-06	6.32e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—AKT1—liver cancer	8.5e-06	6.19e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CB—liver cancer	8.39e-06	6.11e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CG—liver cancer	8.28e-06	6.02e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYCS—liver cancer	8.28e-06	6.02e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CB—liver cancer	8.2e-06	5.97e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CD—liver cancer	8.15e-06	5.93e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GGT1—liver cancer	8.12e-06	5.91e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GOT1—liver cancer	8.12e-06	5.91e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ALB—liver cancer	8.05e-06	5.86e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PPARG—liver cancer	7.99e-06	5.81e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.92e-06	5.76e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CG—liver cancer	7.55e-06	5.49e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTP1—liver cancer	7.3e-06	5.31e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PPARG—liver cancer	7.28e-06	5.3e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CD—liver cancer	7.28e-06	5.3e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HMOX1—liver cancer	7.19e-06	5.24e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ALB—liver cancer	7.18e-06	5.23e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CB—liver cancer	7.11e-06	5.17e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CA—liver cancer	6.92e-06	5.03e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CA—liver cancer	6.71e-06	4.88e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTM1—liver cancer	6.7e-06	4.88e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CD—liver cancer	6.64e-06	4.83e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALB—liver cancer	6.55e-06	4.77e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP1A1—liver cancer	6.36e-06	4.62e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CB—liver cancer	6.34e-06	4.62e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CA—liver cancer	6.34e-06	4.61e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—MTHFR—liver cancer	5.92e-06	4.31e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PPARA—liver cancer	5.81e-06	4.23e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CB—liver cancer	5.78e-06	4.21e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—AKT1—liver cancer	5.65e-06	4.11e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—AKT1—liver cancer	5.48e-06	3.99e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—AKT1—liver cancer	5.18e-06	3.77e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CA—liver cancer	5.12e-06	3.72e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CA—liver cancer	5e-06	3.64e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CG—liver cancer	4.98e-06	3.62e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PPARG—liver cancer	4.8e-06	3.5e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CD—liver cancer	4.38e-06	3.18e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CA—liver cancer	4.33e-06	3.15e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALB—liver cancer	4.32e-06	3.14e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—AKT1—liver cancer	4.18e-06	3.04e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—AKT1—liver cancer	4.09e-06	2.97e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CA—liver cancer	3.87e-06	2.81e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CB—liver cancer	3.81e-06	2.78e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—AKT1—liver cancer	3.54e-06	2.58e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CA—liver cancer	3.53e-06	2.57e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—AKT1—liver cancer	3.16e-06	2.3e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AKT1—liver cancer	2.88e-06	2.1e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CA—liver cancer	2.33e-06	1.69e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AKT1—liver cancer	1.9e-06	1.38e-05	CbGpPWpGaD
